The FDA and Prescription Pancreatic Enzyme Product Cost

American Journal of Gastroenterology - United States
doi 10.1038/ajg.2013.430
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

New Product Development Considering Product Cannibalization, Development Cost and Production Cost

Journal of the Operations Research Society of Japan
Management ScienceDecision SciencesOperations Research
2016English

Medicaid Cost Containment and Access to Prescription Drugs

Health Affairs
MedicineHealth Policy
2005English

Pancreatic Enzyme Replacement Therapy in the Course of Chronic Pancreatitis and Pancreatic Cancer

Effective Pharmacotherapy
2019English

Deregulating Direct‐to‐Consumer Marketing of Prescription Drugs: Effects on Prescription and Over‐the‐Counter Product Sales

Journal of Law and Economics
LawEconomicsEconometrics
2002English

Product Differentiation and Cost Pass-Through

Journal of Agricultural Economics
AgriculturalEconomicsEconometricsBiological Sciences
2019English

The Role and Impact of Cost-Sharing Mechanisms for Prescription Drug Coverage

CMAJ
Medicine
2017English

Structures of Argininosuccinate Synthetase in Enzyme-Atp Substrates and Enzyme-Amp Product Forms

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2003English

The FDA-approved Natural Product Dihydroergocristine Reduces the Production of the Alzheimer’s Disease Amyloid-Β Peptides

Scientific Reports
Multidisciplinary
2015English

Chemical Screen Identifies FDA-approved Drugs and Target Pathways That Induce Precocious Pancreatic Endocrine Differentiation

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy